Skip to content
Esta página está disponible en españolCambiar →

Great investors · David Einhorn · Q2 2025

What David Einhorn bought and sold in Q2 2025

Greenlight Capital (DME Capital Management) 13F portfolio as of Jun 30, 2025: 34 positions worth $2.3 bn. Largest: GRBK, FLR, CNR, BHF. Filed with the SEC on Aug 14, 2025.

The 13F is filed by Greenlight Capital (DME Capital Management), not by David Einhorn personally: these are the whole firm's positions. A “position” is a distinct security in the filing (by CUSIP); share classes of the same company are shown added together.

Buys in Q2 2025

Sells in Q2 2025

13 companies with material moves, out of 23 positions with a change. Only moves of 0.5 points of the portfolio or more are listed, measured as “traded weight” (what was bought or sold, excluding price effects). Smaller changes exist and are not listed: a position may have gone up or down without appearing above.

The full 13F, line by line

Greenlight Capital (DME Capital Management)'s Q2 2025 13F lists 34 lines of US-listed securities worth $2.3 bn; the largest is GRBK at 25.6% of the portfolio. It was accepted by the SEC on Aug 14, 2025 at 11:30 AM ET.

Against the previous quarter, it opened 4 positions (FLR, CI, VSXY and SHC), closed 3 (VTRS, DLTR and ALIT), added to 8 (TEVA, GPK, ACHC and WFRD and 4 more) and trimmed 8 (KD, ROIV, CNR and GLD and 4 more). 14 lines show the same number of shares.

#CompanySharesValueWeightChange in shares
1Green Brick Partners GRBK9.5 M$595M25.6%no change
2Fluor FLR3.8 M$196M8.42%new
3Core Natural Resources CNR2.2 M$150M6.46%−2.4%
4Brighthouse Financial BHF2.8 M$148M6.38%−1.5%
5Kyndryl Holdings KD3.3 M$139M5.97%−20%
6PENN Entertainment PENN7.5 M$134M5.76%+20%
7CNH Industrial CNH7.9 M$102M4.39%−2.5%
8Graphic Packaging Holding GPK4.7 M$99.2M4.26%+349%
9DHT Holdings DHT7.6 M$82.4M3.54%+15%
10TECK Resources TECK2.0 M$80.8M3.47%no change
11HP HPQ3.0 M$73.8M3.17%no change
12TEVA Pharmaceutical Industries TEVA3.8 M$63.3M2.72%+565%
13Capri Holdings CPRI3.5 M$61.6M2.65%no change
14Liberty Global LBTYA5.2 M$52.3M2.25%no change
15SPDR Gold Shares ETF GLD169,411$51.6M2.22%−6%
16Roivant Sciences ROIV4.6 M$51.3M2.21%−16%
17Weatherford International WFRD960,810$48.3M2.08%+110%
18Centene CNC839,170$45.6M1.96%+53%
19Seadrill SDRL1.6 M$41.7M1.79%no change
20Cigna Group CI93,750$31.0M1.33%new
21Acadia Healthcare ACHC865,011$19.6M0.84%+616%
22Victoria's Secret VSXY887,750$16.4M0.71%new
23Lakefront Biotherapeutics LKFT482,746$13.5M0.58%no change
24Coya Therapeutics COYA1.6 M$9.5M0.41%no change
25TD Synnex SNX33,270$4.5M0.19%−28%
26Vaneck ETF Trust GDX76,460$4.0M0.17%no change
27Vaneck ETF Trust OIH15,940$3.7M0.16%+29%
28Sotera Health SHC233,690$2.6M0.11%new
29GoPro GPRO2.8 M$2.1M0.09%no change
30Peloton Interactive PTON179,470$1.2M0.05%−96%
31Gain Therapeutics GANX566,130$1.0M0.04%no change
32Nuvation Bio NUVB34,995$68.2K0.00%no change
33Nuvation Bio NUVB/WS100,000$27.0K0.00%no change
34Katapult Holdings 262,227$2.1K0.00%no change

Positions it closed (3)

One row per line of the filing (by CUSIP): share classes of the same company are listed separately here. “Change in shares” compares the count with the previous quarter, split-adjusted; the value is the one reported in the 13F at quarter end, not today's price.

Original documents: Greenlight Capital (DME Capital Management)'s 13F filings on EDGAR (SEC) ↗

Follow David Einhorn and see their Q3 2026 13F once it is filed

Free. We email you (if you turn it on) and in Following you see what each manager you follow bought and sold.

Follow David Einhorn

Source: 13F filings with the SEC. A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions. Not investment advice.

Follow David Einhorn for free

When the next 13F is filed, we email you (if you turn it on) and it shows in your list. No credit card.

Follow David Einhorn